OptimizeRx (OPRX) Retained Earnings (2016 - 2025)
OptimizeRx (OPRX) has disclosed Retained Earnings for 16 consecutive years, with -$79.2 million as the latest value for Q4 2025.
- Quarterly Retained Earnings rose 6.08% to -$79.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$79.2 million through Dec 2025, up 6.08% year-over-year, with the annual reading at -$79.2 million for FY2025, 6.08% up from the prior year.
- Retained Earnings hit -$79.2 million in Q4 2025 for OptimizeRx, up from -$84.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$35.3 million in Q4 2021 to a low of -$86.6 million in Q1 2025.
- Historically, Retained Earnings has averaged -$60.2 million across 5 years, with a median of -$58.7 million in 2023.
- Biggest five-year swings in Retained Earnings: tumbled 40.21% in 2024 and later increased 6.08% in 2025.
- Year by year, Retained Earnings stood at -$35.3 million in 2021, then plummeted by 32.45% to -$46.7 million in 2022, then crashed by 37.62% to -$64.3 million in 2023, then plummeted by 31.3% to -$84.4 million in 2024, then rose by 6.08% to -$79.2 million in 2025.
- Business Quant data shows Retained Earnings for OPRX at -$79.2 million in Q4 2025, -$84.3 million in Q3 2025, and -$85.0 million in Q2 2025.